This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
03 Dec 2013 | North America | Market Research
Analysis of the Global Tissue Diagnostics Market
Reimbursement Cuts and Hospital Consolidation Impede Uptake of Automated Equipment in Laboratories
This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forec...
$10,000.00 -
22 Nov 2013 | North America | Market Research
Vital Signs - Strategies beyond BRIC: An Update on the African In Vitro Diagnostics Market
This issue of Vital Signs, released on November 22, 2013, provides overview of global IVD market dynamics, discuss growth strategy, and explore early opportunities in the African IVD market. Additionally, a company spotlight is provided for Global BioDiagnostics based in Temple, Texas. The company is focused on developing affordable diagnostic tes...
$450.00 -
31 Oct 2013 | North America | Market Research
Vital Signs - Healthcare News - The Analysts Perspective October 2013 Issue
This issue of Vital Signs, released on October 31, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, and Advanced Medical Technology.
$450.00 -
07 Oct 2013 | North America | Market Research
Vital Signs - Health Insurance Exchanges: Real-Time Analyst Insights on HIX September 2013
Given the importance of the changes from PPACA and the creation of the health insurance marketplaces, we are providing our online Frost.com blog on HIX in collected form for the month of September for ease of use by our subscription clients. This discussion is brought to you by our Connected Health research program. Please also follow our blog, par...
$450.00 -
30 Sep 2013 | North America | Market Research
Vital Signs - The Global Market for Type 2 Diabetes Therapeutics
This issue of Vital Signs, released on September 30, 2013, provides a market overview and drug pipeline analysis of Type 2 diabetes therapeutics. Additionally, a company spotlight is provided for Trovagene in San Diego, CA. The company has a proprietary transrenal nucleic acid platform with the potential to deliver superior molecular diagnostics i...
$450.00 -
30 Sep 2013 | North America | Market Research
Vital Signs - Healthcare News - The Analysts Perspective September 2013 Issue
This issue of Vital Signs, released on September 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, Advanced Medical Technology and Connected Health.
$450.00 -
26 Sep 2013 | North America | Market Research
US Medical Radiopharmaceuticals Market
New Growth Opportunities Emerge in a Strenuous Market
This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as wit...
$4,950.00 -
12 Sep 2013 | North America | Market Research
Vital Signs - Health Insurance Exchanges: Real-Time Analyst Insights on HIX August 2013
Given the importance of the changes from PPACA and the creation of the health insurance marketplaces, we are providing our online Frost.com blog on HIX in collected form for the month of August for ease of use by our subscription clients. This discussion is brought to you by our Connected Health research program. Please also follow our blog, part o...
$450.00 -
31 Aug 2013 | North America | Market Research
Vital Signs - Healthcare News - The Analysts Perspective August 2013 Issue
This issue of Vital Signs, released on August 31, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, Advanced Medical Technology and Connected Health.
$450.00 -
31 Jul 2013 | North America | Market Research
Vital Signs - Sequestration Paints Bleak Outlook for Life Science Research Tools Suppliers
This issue of Vital Signs, released on July 31, 2013, provides an analysis of sequestration measures that were in effect March 1st, 2013 on academic and government laboratory spending on life science research tools and products. Additionally, a company spotlight is provided for BioScale in Lexington, MA. The company provides a highly innovative pr...
$450.00
